Gerard Ber, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 722 shares at $12.00 ($9K) on 2024-06-10, disclosed to the SEC on 2024-06-11.
Open-market sale of $9k YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |